arrow
L

Lichchavi D. Rajasinghe

AstraZeneca
H指数:10
被引数:284

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Preclinical characterization of AZD1163, a first-in-class anti-PAD2/4 bispecific antibody for the treatment of rheumatoid arthritis

AZD1163的预临床表征,一种用于治疗类风湿关节炎的首创抗PAD2/4双特异性抗体

mAbs
IF7.3
2026-04-150
OA
Comparative effects of human-equivalent low, moderate, and high dose oral prednisone intake on autoimmunity and glucocorticoid-related toxicity in a murine model of environmental-triggered lupus
2022-10-197
OAAI